Latest advance in precise radiation treatment a powerful addition -- first in the nation

Clinicians and researchers at UT Southwestern involved with the Vero system include (from left) Dr. Robert Timmerman, vice chairman of radiation oncology; Dr. Timothy Solberg, professor of radiation oncology and radiology; Dr. Hak Choy, chairman of radiation oncology; and Dr. Jeffrey Solberg, assistant professor of radiation oncology and in the Cancer Immunobiology Center. Credit: UT Southwestern Medical Center

UT Southwestern Medical Center has installed a new system to deliver extremely precise and individualized radiation treatment, assuring that cancer patients in the region have access to the latest advances in radiation oncology.

The VERO system, the first and only currently operating in the entire Western Hemisphere, allows UT Southwestern to locate and track tumors and more precisely target radiation compared to other technologies. This helps avoid damage to healthy tissues and reduces the number of treatment sessions needed – resulting in better patient outcomes and experiences.

"Radiation oncology at UT Southwestern is unique in all of North America in terms of the breadth of our technology, research and patient care capabilities," said Dr. Hak Choy, chairman of radiation oncology at the medical center. "We are very fortunate to be able to offer many different technologies that enable us to provide the optimal approach tailored to individual patient needs."

Patients at UT Southwestern needing therapeutic radiation have access to 10 state-of-the-art machines: seven linear accelerators, two specialized stereotactic machines (CyberKnife and Gamma Knife) and the VERO – an array of options that distinguishes UT Southwestern Medical Center from other medical centers.

The newest system offers exceptional precision targeting, enabling treatment for patients for whom the risk of damage to nearby non-cancerous precludes further use of standard radiotherapy. It allows doctors to monitor and adapt to each patient's anatomy and to precisely coordinate delivery of radiation with natural movements such as breathing, or in response to changes that can occur between treatments, such as shrinkage or weight loss.

Because a stereotactic approach allows oncologists to deliver radiation in such a concentrated and precise manner, fewer treatment sessions are needed, Dr. Choy said.

Dr. Bruce Meyer, executive vice president for health system affairs at UT Southwestern, said: "As advances are made, we are committed to bringing the most effective therapeutic technologies to patients whose lives depend on receiving the best care from the best doctors armed with the best technology. We owe it to our patients to offer them leading-edge treatment options."

Visit the Department of Radiation or the Harold C. Simmons Cancer Center to learn more about at UT Southwestern, including highly individualized treatments for cancer at the region's only National Cancer Institute-designated center.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Taking the guesswork out of cancer therapy

20 minutes ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

1 hour ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

2 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

Computer model reveals cancer's energy source

3 hours ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

User comments